Vertex Pharma (VRTX) Tops Q4 EPS by 8c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Vertex Pharma (VRTX) Tops Q4 EPS by 8c, Offers Guidance

Vertex (VRTX) is a Clean Revenue Growth Story, Pipeline is Discounted and Stock Remains Preferred - BMO Capital

January 26, 2022 4:46 PM EST

BMO Capital analyst Evan David Seigerman reiterated an Outperform rating and $274.00 price target on Vertex (NASDAQ: VRTX), following recent earnings report.

The analyst quotes: "Bottom line with Vertex is that, while there's been some pipeline challenges (before the positive 147 update), we... More